Wide Range of Cenobamate Doses Associated With Initial Seizure Freedom in Patients With Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study (P12-9.003)

To examine the initial doses of cenobamate that were associated with seizure freedom (SF) in the phase 3 open-label efficacy subset.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000208419
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Wide Range of Cenobamate Doses Associated With Initial Seizure Freedom in Patients With Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study (P12-9.003)

Louis Ferrari, William E. Rosenfeld
Neurology
Epilepsy research and treatment
article

Wide Range of Cenobamate Doses Associated With Initial Seizure Freedom in Patients With Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study (P12-9.003)

Louis Ferrari, William E. Rosenfeld
article en

Abstract

To examine the initial doses of cenobamate that were associated with seizure freedom (SF) in the phase 3 open-label efficacy subset.

NeurologyVol. 104(7_Supplement_1)
Center for Children (US), SK Life Science (United States) (US)
Peace, Justice and strong institutions
Openalex Percentile: Top 92%
Epilepsy research and treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.